Proof of concept non-invasive estimation of peripheral venous oxygen saturation by Khan M et al.
Proof of concept non‑invasive 
estimation of peripheral venous oxygen 
saturation
Musabbir Khan1*, Chris G. Pretty1, Alexander C. Amies1, Joel Balmer1, Houda E. Banna2, Geoffrey M. Shaw2 
and J. Geoffrey Chase1
Abstract 
Background: Pulse oximeters continuously monitor arterial oxygen saturation. Con-
tinuous monitoring of venous oxygen saturation  (SvO2) would enable real-time assess-
ment of tissue oxygen extraction  (O2E) and perfusion changes leading to improved 
diagnosis of clinical conditions, such as sepsis.
Methods: This study presents the proof of concept of a novel pulse oximeter method 
that utilises the compliance difference between arteries and veins to induce artificial 
respiration-like modulations to the peripheral vasculature. These modulations make the 
venous blood pulsatile, which are then detected by a pulse oximeter sensor. The result-
ing photoplethysmograph (PPG) signals from the pulse oximeter are processed and 
analysed to develop a calibration model to estimate regional venous oxygen saturation 
 (SpvO2), in parallel to arterial oxygen saturation estimation  (SpaO2). A clinical study with 
healthy adult volunteers (n = 8) was conducted to assess peripheral  SvO2 using this 
pulse oximeter method. A range of physiologically realistic  SvO2 values were induced 
using arm lift and vascular occlusion tests. Gold standard, arterial and venous blood 
gas measurements were used as reference measurements. Modulation ratios related to 
arterial and venous systems were determined using a frequency domain analysis of the 
PPG signals.
Results: A strong, linear correlation (r2 = 0.95) was found between estimated venous 
modulation ratio  (RVen) and measured  SvO2, providing a calibration curve relating 
measured  RVen to venous oxygen saturation. There is a significant difference in gradient 
between the  SpvO2 estimation model  (SpvO2 = 111 − 40.6*R) and the empirical  SpaO2 
estimation model  (SpaO2 = 110 − 25*R), which yields the expected arterial-venous dif-
ferences. Median venous and arterial oxygen saturation accuracies of paired measure-
ments between pulse oximeter estimated and gold standard measurements were 0.29 
and 0.65%, respectively, showing good accuracy of the pulse oximeter system.
Conclusions: The main outcome of this study is the proof of concept validation of 
a novel pulse oximeter sensor and calibration model to assess peripheral  SvO2, and 
thus  O2E, using the method used in this study. Further validation, improvement, and 
application of this model can aid in clinical diagnosis of microcirculation failures due to 
alterations in oxygen extraction.
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Background
Arterial oxygen saturation  (SaO2) and venous oxygen saturation  (SvO2) are the two 
basic parameters used to assess the oxygen delivery process and monitor oxygen extrac-
tion  (O2E). These two parameters are important for the analysis of whole body oxygen 
circulation.  O2E data could provide an indicator of the adequacy of local tissue perfu-
sion, to aid in the early diagnosis of microcirculatory dysfunction in medical conditions, 
such as in sepsis and cardiogenic shock. Thus, continuous monitoring of both  SaO2 and 
 SvO2 would be useful for haemodynamic and perfusion management in clinical settings, 
according to recent clinical consensus statements [1].
SaO2 can be non-invasively and reliably estimated by pulse oximeters  (SpaO2), using 
photoplethysmograph (PPG) signals produced by an optical sensor, typically mounted 
on a finger, toe, or ear-lobe, to detect blood volume changes. The PPG waveform results 
from the pulsatile variation in the tissue optical density produced by the pulsation of 
arterial blood [2, 3]. Conventional pulse oximetry relies on the pulsatile nature of arte-
rial blood and differential absorption of oxyhaemoglobin and de-oxyhaemoglobin at red 
(RD) and infrared (IR) wavelengths to estimate  SpaO2 [4, 5].
Venous blood in the periphery is typically non-pulsatile in nature. Being dependent 
on pulsatile blood volume changes to make measurements, conventional pulse oximeter 
sensors can only determine  SpaO2. Thus,  SvO2 estimation cannot be provided by con-
ventional pulse oximeters  (SpvO2). Currently, no available commercial equipment pro-
vides continuous, non-invasive measurement or estimate of  SvO2.
Reliable  SvO2 monitoring is an important element of perfusion monitoring and a nec-
essary measure to determine tissue oxygen extraction capability, which can be used as a 
clinical marker of microcirculatory failures. In addition, continuous monitoring of the 
difference between  SaO2 and  SvO2 would enable the tracking of alterations in tissue per-
fusion, in real-time. These alterations are very common in sepsis patients [6]. Thus, con-
tinuous and simultaneous  SpaO2 and  SpvO2 estimation by pulse oximeter could be used 
as an indicator of tissue  O2E and perfusion changes in response to patient condition or 
treatment.
Prior studies have investigated non-invasive methods using PPG and near infrared 
spectroscopy (NIRS) sensors to assess  SpvO2. However, the results of these studies have 
not been conclusive, or have not been validated against a reliable measurement. Two 
previous studies attempted to assess  SpvO2 by inducing pulsations to the venous sys-
tem, but failed to provide physiologically realistic values of  SpvO2 [7, 8]. Some stud-
ies reported physiologically realistic  SvO2 estimates, but did not validate their results 
against gold standard measurements [9–12]. Other studies used reference measurement 
for comparison, but cannot provide continuous and simultaneous measurement of both 
 SpaO2 and  SpvO2 [13, 14]. These limitations of prior studies reduce the clinical applica-
bility of their methods.
Venous walls are significantly thinner and less elastic than arterial walls. In particular, 
the veins are up to 10–20 times more compliant compared to arteries under low pres-
sure [15–17]. With relatively small changes in pressure, the circulating blood inside the 
much more compliant veins experiences large volume changes compared to the arteries 
[16, 18]. This large compliance difference is what causes the venous blood of the oesoph-
agus regions to modulate at respiratory frequency seen in previous studies [16, 18], and 
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is illustrated in Fig. 1. Hence, this compliance difference can be exploited to artificially 
induce modulations at respiratory frequency and low pressure in the venous system, 
without disturbing arterial blood flow [19], which can be measured using PPG.
This study presents the initial proof of concept for a novel pulse oximeter method to 
assess peripheral  SpvO2, in addition to  SpaO2, leveraging this arterial-venous compli-
ance difference. An artificial pulse generation (APG) system was developed to artificially 
modulate the peripheral venous blood using a digit pressure cuff. These modulations 
are detected by a pulse oximeter sensor and the resultant PPG signals are extracted for 
analysis. The measured transmission from the PPG signal related to venous blood and 
the  SvO2 from gold standard blood gas measurement were used to develop a calibration 
curve. The main outcome of this study is a proof of the concept and a calibration curve 
to estimate  SpvO2 and accuracy of the sensor.
Methods
APG system development and operation
An APG system was developed in this study to exploit the significant arterial-venous 
compliance difference to induce artificial pulsations predominantly in the venous com-
partment. The complete APG system is shown schematically in Fig. 1. This system uses 
a pneumatic UDC2.5 (D.E. Hokanson Inc., Bellevue, WA, USA) digit cuff placed at the 
intermediate phalanges of the middle finger, as shown in Fig. 2, to mechanically modu-
late venous blood in the finger. By periodically inflating and deflating the digit cuff, an 
artificial respiration-like pulse can be induced onto the venous blood of the finger.
Inflation/deflation of the digit cuff is controlled by a 3-way solenoid valve (EVT 
307-5DZ-02F-Q, SMC, Noblesville, IN, USA). Operation of the solenoid valve is man-
aged by a PC running LabVIEW through a NI cDAQ-9172 (National Instruments, Aus-
tin, TX, USA) multifunction data acquisition device (DAQ). The solenoid is switched on 
and off with square pulses at 0.2 Hz and 50% duty cycle. The 0.2 Hz frequency is close to 
typical respiratory frequencies to create artificial venous blood modulations, like those 
previously reported by Walton et al. [9] when detecting natural venous blood modula-
tions in the oesophagus using a PPG sensor.
Fig. 1 APG system functional block diagram illustrating overall operation
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A precision pressure regulator (AS1002F, SMC, Noblesville, IN, USA) was used to 
control the pressure of air supplied to inflate the cuff at 40–50 mmHg, which is approxi-
mately 50% below typical diastolic arterial pressures. Thus, this cuff compression pres-
sure will predominantly effect the venous compartment. For the deflation portion of the 
pulse, the air in the cuff was exhausted to the atmosphere with the solenoid valve turn-
ing off.
Study cohort
Ethics approval for this study was granted by the Human Disability an Ethics Commit-
tee, New Zealand (Reference: 15/CEN/141). This study was conducted in the intensive 
care unit (ICU) of St George’s Hospital, Christchurch. Eight healthy adult, male, volun-
teers (aged 23–37  years) with no pre-existing medical conditions were recruited, and 
provided signed, informed consent. Table  1 provides subject demographics including 
age, sex, height, weight, body mass index (BMI), resting blood pressure (BP), and rest-
ing heart rate (HR). This study was an initial proof of concept testing using healthy adult 
volunteers and was not about testing full range of people, age, gender or other condition.
Equipment set up
The equipment for this experiment is shown in Fig. 3 and was set up as follows:
  • An arterial catheter (20 or 22 g) was inserted into the left radial artery under sterile 
conditions using a small amount (0.2  ml) of subcutaneous local anaesthetic (lido-
caine 1%). Similarly, a 20–22 g IV catheter was inserted into a vein on the back of the 
left hand. Both catheters were connected to an ‘intraflow’ device, which delivered 
about 3 ml per hour of 0.9% saline through the arterial catheter. A portable i-Stat1 
blood gas analyser (Abbott, Princeton, NJ, USA) was employed to analyse catheter 
drawn blood samples.
  • A standard transmission mode sensor (model: 320701001, Biometric Cables, Guindy, 
Chennai, India), connected to the custom pulse oximeter (PO) system, was clipped 
to the index/middle finger of the left hand.
Fig. 2 Digit cuff placement adjacent to the PPG sensor
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  • A Masimo (Masimo Corporation, Irvine, CA, USA) SET pulse oximeter sensor was 
clipped to the ring finger of the left hand and connected to a portable DASH 5000 
(GE Healthcare, Chicago, Illnois, USA) monitoring screen as a reference measure-
ment for  SpaO2 and HR.
  • A thermocouple was attached next to the PO sensor on the skin surface to continu-
ously monitor digit skin temperature.
  • A conventional blood pressure cuff was wrapped around the participant’s left fore-
arm to make blood pressure measurements and perform vascular occlusion test 
(VOT), according to the experimental protocol.
Experimental protocol
Subjects were asked to refrain from smoking and strenuous physical activities for at least 
4 h prior to the experiment. During the study, subjects were comfortably seated, while 
resting their left arm on a flat surface at approximately the same height as their heart and 
Table 1 Subject demographics for this study




1 30 M 1.75 74.40 24.16 125/68 52
2 24 M 1.78 69.00 21.78 106/49 73
3 37 M 1.83 75.00 22.40 120/63 66
4 23 M 1.71 70.00 23.94 131/78 76
5 24 M 1.68 55.00 19.49 117/56 65
6 27 M 1.68 71.50 25.51 120/70 68
7 30 M 1.80 93.00 28.70 134/87 69
8 25 M 1.70 65.00 22.49 109/55 68
Fig. 3 Typical equipment set up for this study. Key components are labelled. 1 dash monitoring screen, 2 
air supply and regulator, 3 PO sensor, 4 thermocouple sensor, 5 digit pressure cuff, 6 blood pressure cuff, 7 
venous line and catheter, 8 masimo SET sensor, 9 PO system, 10 solenoid vales, 11 pressure gauge, 12 PC run-
ning LABVIEW, 13 ITV001 pressure regulator, 14 NI DAQ system, 15 power supplies
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with minimum movement. During the study, 3 tests were performed to achieve a wide 
range of  SvO2 values and provide a valid dataset.
  • At the beginning of the study, resting HR, resting BP, height, weight, and BMI were 
recorded, as presented in Table 1. Two minutes of baseline PPG data were recorded 
without any APG activation.
  • Subjects were asked to perform the following tests as part of the study protocol:
a. Test 1: Hold left arm at chest level, referred to as baseline.
b. Test 2: Raise left arm above the head for 10 min.
c. Test 3: Allow pressure cuff induced vascular occlusions for 4–6 min using pres-
sures of 170 mmHg, which are above typical systolic pressures to stop all flow to 
the hand.
  • 2 ml sample of blood was drawn during each test as follows:
a. Test 1: 1× arterial sample, 1× venous sample after 1 min of APG activation.
b. Test 2: 1× arterial sample (Subjects 1–5 only) and 1× venous sample at 4 min 
after the arm was raised.
c. Test 3: 1× venous sample immediately before the pressure cuff was released, and 
1× venous sample at 30 s into post occlusion.
Up to a total of 8 blood samples were drawn from each participant. Each blood sample 
was approximately 2 ml and maximal total blood volume approximately 16 ml. The cath-
eters were flushed with 0.9% saline (1–3 ml) after each blood draw. Subjects 7 and 8 had 
2× venous samples taken during Test 1 to get more baseline measurements and increase 
the number of overall data samples for analysis.
•  APG operation and blood sampling times for the tests are illustrated in Fig. 4:
For Subjects 1–5,  SaO2 measurements did not vary more than ±1.02% of the baseline 
measurements (Test 1) for any tests. Since  SaO2 unlikely to vary with any change in local 
conditions for a healthy adult, only one arterial sample was drawn during Test 1 as a ref-
erence sample for Subjects 6–8. Thus, no other arterial samples were obtained during 
Tests 2 and 3 for Subjects 6–8 to simplify the study and reduce burden, since the primary 
goal is to assess the  SvO2 provided versus gold standard measures of the same  SvO2.
Fig. 4 Timeline for the overall experimental protocol, including APG operations and blood sampling times 
for each test. Participants were not asked to complete more than 2 runs through the protocol. AS refers to 
arterial blood sample. VS refers to venous blood sample
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Test 2 was investigated for Subjects 1–5 only to detect any change in  SvO2 using the 
PO sensor and APG system. When the arm is raised above heart level, the mean arterial 
blood pressure and flow is reduced, and thus a drop in  SvO2 can occur. During testing, it 
proved difficult to reliably draw blood samples with the lowered venous flow and pres-
sure, meaning a range of induced oxygenation levels could not be effectively achieved. 
Thus, Test 3 was developed to improve reliability and ease of blood sampling for a simi-
lar induced change, where it is important to note that inducing a range of oxygenation 
levels is the only necessity in this initial proof of concept study whose goal is to provide 
initial validation of the potential to accurately capture a wide range of venous oxygena-
tion levels.
More specifically, Test 3 was conducted as an alternate technique to cause a more 
repeatable and more easily induced significant drop in  SvO2. Several minutes of ischemia 
is likely to induce a large reduction in overall oxygen saturation, including  SvO2, in the 
ischemic region. It should be noted that Test 3 was repeated for Subjects 6–8 for 4 and 
6 min of vascular occlusions, while Subject 5 being the first for Test 3 was only tested 
for 4 min of occlusion as the protocol was still being developed. Thus, Test 3 not only 
induced a larger  SvO2 change but was also more reliable, repeatable, and easier to imple-
ment compared to Test 2.
PPG acquisition and sampling
PPG finger sensor control and data acquisition were managed with the PO system, 
which includes serial communication and a graphical interface. The PO system is based 
on the CY8CKIT-050 PSoC 5LP Development Kit (Cypress Semiconductor, San Jose, 
CA, USA) that has an ARM Cortex M3 microcontroller. The PPG sensor uses 660 and 
940 nm wavelengths for the RD and IR LEDs, respectively, and a very sensitive photode-
tector (PD). Feedback control was used by the PO system microcontroller to adjust LED 
intensities specific to finger thickness.
Light energy received at the PD was converted to current signals and passed through 
a two stage transimpedance amplifier for signal conditioning. A de-multiplexer splits 
the conditioned PPG signals so that the RD and IR PPGs are processed independently. 
Analog PPG signals in the range 0–5 V were sampled at 50 Hz by a 16-bit analog-to-
digital converter (ADC) on the development board. Sampled data were sent to a PC via 
serial communication and recorded for offline signal processing in MATLAB (R2014a, 
MathWorks, Natick, MA, USA).
Data processing and analysis
A two-stage digital filter system was implemented to extract the PPG signals of inter-
est from the raw and amplified PPG data. Zero phase (forward–reverse) filtering was 
applied at each filter stage to reduce phase distortion and maintain PPG waveform 
shape.
The first filter stage was a 170th order, equiripple, low-pass, FIR filter with a cut-off fre-
quency of 10 Hz and attenuation of 50 dB to effectively remove any unwanted, high fre-
quency noise from the PPG signals [20]. The second filter stage had three parallel filters 
to separately extract high frequency (AC), APG modulated frequency (APG), and very 
low frequency (DC) signals. An empirically derived 4th order band-pass, Butterworth, 
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IIR filter extracted AC signals, such as the cardiac frequencies, with pass band frequen-
cies of 0.67–4.5 Hz. An empirically derived 12th order band-pass, Butterworth, IIR fil-
ter extracted APG signals with pass band frequencies of 0.15–0.67 Hz. An empirically 
derived 6th order low-pass, Butterworth, IIR filter with a cut-off frequency of 0.15 Hz 
was used to extract DC signals between 0 and 0.15 Hz.
A Fast Fourier Transform (FFT) analysis was used to determine the relative power in 
each part of the PPG signal to calculate the “modulation ratios” (R values):
where,
  • RArt is the modulation ratio related to arterial blood.
  • RVen is the modulation ratio related to venous blood.
  • |AC|HR is the peak Fourier magnitude of the AC signal, related to cardiac frequency.
  • |APG|0.2 Hz is the peak Fourier magnitude at 0.2 Hz of the APG signal.
  • |DC|0 Hz is the peak Fourier magnitude at 0 Hz frequency of the DC signal.
The fundamental frequency associated with the peak magnitude was identified from 
the frequency power spectra of AC, APG, and DC offset signals, as shown in Fig.  5. 
Equations 1 and 2 were then used to compute values of  RArt and  RVen. Frequency power 
spectra were obtained using the FFT on PPG data blocks of 20  s duration (n =  1000 
samples), yielding a frequency resolution of 0.025 Hz. Each 20 s block corresponded to a 
blood sample, enabling comparison between measured and estimated saturation values. 
Blocks of 20 s were short enough to allow analysis of transient effects in Test 3, while still 
providing good frequency resolution.
A linear model was fitted to the calculated  RVen values and measured blood gas  SvO2, 
and the coefficient of determination (r2) was computed to assess the strength of their 
correlation. The linear model was then used as the calibration curve to estimate  SpvO2 
for each  RVen. The Wilcoxon signed rank test was used to compare paired values of meas-
urements, including  RVen and  RArt for each subject, over the experimental cohort. p val-
ues of p < 0.05 were considered statistically significant.
Error propagation analysis, using linear and non-linear combinations [21], was imple-
mented to calculate uncertainties for measured  SvO2 (δSvO2) and  RVen (δRVen). The clin-
ical data defined in the Abbott i-Stat1 device manual [22] and the uncertainty of the PO 
sensor for  SpaO2 measurement [23, 24] were used in the analysis.
Results
Detection of AC and APG signals from PPG
Figure 6 shows an example of the post-processed PPG signals detected by the PO sensor, 
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effectively constant since the APG system was not activated, while the AC signal pulsed 
due to the cardiac cycle. Upon activation of the APG system at approximately 130 s, the 
APG signal showed a period oscillation with an amplitude of up to 0.06 V.
Correlation between  RVen and  SvO2
Table  2 presents all the estimated  RVen values and measured blood gas  SvO2 samples, 
including their estimated uncertainties, for each subject in all the tests (n =  21). The 
correlation between these two measurements is shown in Fig. 7. A strong, negative cor-
relation is found between the two measurements, with r2 = 0.95. The linear model fitted 
Fig. 5 Frequency power spectrums of the AC, APG, and DC filter bands for Subject 7 from Test 1. Top panels: 
RD and bottom panels: IR
Fig. 6 Baseline PPG signals showing pre APG and post APG phases for Subject 7; top-bottom AC signal, APG 
signal, DC Signal, and RAW signal
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through the data points shows a good association between  RVen and  SvO2 and explains 
all but 5% of the variation. In addition, the gradient (−40.5%) of this model is different to 
the gradient (−25.0%) of the empirical  SpaO2 estimation model commonly used in pulse 
oximeter estimation [25] and shown on Fig. 7 for comparison.
Most of the data points are in close proximity to the fitted linear model. The data point 
at R = 1.7,  SvO2 = 42% could have some influence on the liner fit due to its distance 
from the other points. In this case, exclusion of this point still shows a strong correlation 
(r2 = 0.92) between the two measured and calculated values, indicating the point does 
not significantly affect the overall correlation.
Measured and estimated data
Table  3 summarizes all measured and estimated oxygen saturation values, including 
their paired differences, and R values for the three tests. Using the empirical pulse oxi-
meter calibration equation for  SpaO2, shown in Fig. 7, the median difference between 
 SaO2 and  SpaO2 was 0.65 [Inter Quartile Range (IQR) −0.98 to 1.51%] . The median dif-
ference between  SvO2 and  SpvO2, determined using the calibration equation derived for 
 SvO2 developed in this study, was just 0.29 [IQR −2.05 to 1.27%] .
The  RVen determined across all the subjects for each protocol were lower and signifi-
cantly different (p < 0.001) to the corresponding  RArt, as expected. The overall median 
difference between estimated  SpaO2 and  SpvO2 across the 3 tests was 13.8%, and posi-
tive, as expected. In addition, the difference between pairs of measurements in each sub-
ject was statistically significant (p < 0.001).
Table 2 Estimated  RVen, measured  SvO2, and  related uncertainties for  each subject 
from the whole study
Subject RVen δRVen SvO2% δSvO2
1 0.64 0.03 82.00 3.99
0.70 0.03 79.00 3.85
2 0.55 0.02 91.00 4.43
3 0.63 0.03 82.00 3.99
0.52 0.02 91.00 4.43
4 0.87 0.04 76.00 3.70
0.97 0.04 74.00 3.60
5 0.43 0.02 94.00 4.58
0.46 0.02 93.00 4.53
1.07 0.05 64.00 3.12
6 0.68 0.03 82.00 3.99
1.23 0.05 59.00 2.87
1.70 0.07 42.00 2.05
7 0.71 0.03 83.00 4.04
0.62 0.03 85.00 4.14
0.79 0.03 78.00 3.80
1.24 0.05 66.00 3.21
8 0.67 0.03 88.00 4.29
0.47 0.02 92.00 4.48
0.99 0.04 77.00 3.75
1.17 0.05 59.00 2.87
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Discussion
This study demonstrates that peripheral  SvO2 can be reliably and accurately estimated 
using the PO and APG systems, described, and the calibration curve presented. Very 
good correlation is found between estimated  RVen and measured  SvO2 across all the sub-
jects in the 3 tests (r2 = 0.95) across a wide range of  SvO2 values, as shown in Fig. 7. The 
negative correlation is expected and in accordance to the empirically derived  RArt value 
and measured  SaO2 in other studies [25–27]. This relationship allows determination of 
 SvO2 from  RVen, as obtained using the APG system. Thus, the linear fit and very high r2 
value indicates the applicability of the metric in assessment of  SvO2 and  O2E in future 
studies.
Using this calibration model, the median (IQR) difference between pairs of measured 
and estimated venous oxygen saturation values was calculated to be 0.29% [−2.05 to 
1.27%], which is less than the measurement error from the reference i-Stat blood gas 
analyzer. Using the empirical pulse oximeter calibration model, the median [IQR] dif-
ference between pairs of measured and estimated arterial oxygen saturation values was 
calculated to be 0.65% [−0.98 to 1.51%]. Thus, venous oxygen saturation accuracies from 
this pulse oximeter system are expected to be similar to those commonly obtained for 
arterial oxygen saturations.
The relationship between the PPG signal modulation ratio (R) and the oxygen satura-
tion is associated with the bulk tissue’s optical properties. Modulation induced artefacts 
can have a measurable impact on the relative optical properties of the tissue medium 
being investigated using PPG [28]. Such artefacts in a limb may simulate the effects of 
tissue hemoglobin concentration variations of the tissues medium. These variations can 
Fig. 7 Correlation (r2 = 0.95) between all estimated  RVen and measured  SvO2 samples across the whole 
cohort from the 3 tests. The solid blue line is the proposed  SpvO2 calibration model and the dashed red line is 
the empirical  SpaO2 calibration model related to  RArt [25]
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result in different R values derived from PPG measurements when compared to non-
modulated PPG measurements, as seen in previous studies [28, 29].
The good relationship between  RVen and  SvO2 obtained in this study suggest the low 
pressure external modulations caused by the APG system impacted almost exclusively 
the venous system, due to the significant arterial-venous compliance difference. There-
fore,  RVen values derived from the APG and DC offset signals are different to  RArt values 
derived from the AC and DC offset signals.
When the arm is completely occluded above systolic blood pressures, arterial blood 
supply to the arm is stopped. During Test 3, the arm was occluded and blood flow to 
the arm was restricted for several minutes. Without any perfusion it is expected that the 
occluded blood will slowly desaturate of oxygen over time [30–33]. The oxygen present 
in the occluded blood will gradually diffuse to nearby tissues due to the hypoxic con-
dition created by low oxygen tension or  PO2 in the occluded region. Hence, the lower 
 SpvO2 and  SpaO2 values in Test 3 and Table 3.
In Test 3, a venous sample was taken immediately before the arm pressure cuff was 
completely deflated to get a measure of the true ischemic, oxygen desaturated blood. The 
APG was activated just before releasing the pressure cuff, and thus, the first few APG 
pulses capture the true ischemic blood. The APG pulse amplitude of the RD signal was 
Table 3 Measured and estimated data for all the subjects across the three tests
Some subjects do not have measured values as explained in “Experimental protocal”.  SpaO2 estimated using 110 − 25*RArt 
and  SvO2 estimated using 111 − 40.5*RVen
Test Sub-
ject
RVen SpvO2% SvO2% SvO2 − SpvO2% RArt SpaO2% SaO2% SaO2 − SpaO2%
1 1 0.64 84.97 82 −2.97 0.56 96.02 97 0.98
2 0.55 88.6 91 2.4 0.52 96.91 98 1.09
3 0.63 85.45 82 −3.45 0.58 95.62 98 2.38
4 0.87 75.5 76 0.5 0.55 96.16 96 −0.16
5 0.43 93.32 94 0.68 0.48 98 97 −1
6 0.68 83.2 82 −1.2 0.47 98.16 97 −1.16
7 0.71 82.08 83 0.92 0.63 94.34 97 2.66
0.62 85.83 85 −0.83 0.58 – – –
8 0.67 83.5 88 4.5 0.57 95.74 97 1.26
0.47 91.71 92 0.29 0.53 – – –
2 1 0.7 82.35 79 −3.35 0.53 96.87 99 2.13
3 0.52 89.73 91 1.27 0.47 98.2 97 −1.2
4 0.97 71.53 74 2.47 0.52 97.02 96 −1.02
5 0.46 92.2 93 0.8 0.48 97.91 97 −0.91
3 5 1.07 67.39 64 −3.39 0.69 – – –
6 1.23 61.05 59 −2.05 0.7 – – –
1.7 42.08 42 −0.08 0.68 – – –
7 0.79 78.73 78 −0.73 0.52 – – –
1.24 60.75 66 5.25 0.76 – – –
8 0.99 70.5 77 6.5 0.55 – – –
1.17 63.46 59 −4.46 0.62 – – –
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expected to be greater than the IR signal during such low saturation phase [34, 35]. This 
effect in the time domain PPG signals also has an equal effect to the PPG signals in the 
frequency domain. Thus, higher than baseline  RVen values are observed in the Recovery 
1 phase of Test 3. In addition, due to the greater inaccuracy of the wavelengths used at 
saturation <70% [29], the error in measurement is also larger for those  RVen values.
During the occlusion phase of Test 3, the local tissue was being deprived of oxygen 
by the lack of perfusion. Previous studies have shown that tissues will temporarily 
increase extraction of oxygen from blood to return to normal tissue saturation level after 
ischemia [31, 36, 37]. Thus, when the cuff is released after this brief ischemia the local 
tissues and muscles in the arm increased extraction of oxygen, which is evident across all 
the subjects in Test 3, as seen in Table 3.
The recovery of oxygen desaturated blood to baseline oxygen saturation level after 
ischemia is very rapid during reactive hyperemia in healthy adults [30, 33]. For Subjects 
5 and 6, a venous sample was taken approximately 30  s after blood flow was restored 
to the arm. Blood gas analysis of those samples revealed  SvO2 had already returned to 
baseline level. Thus, the rapid change from low saturation to normal occurred in less 
than 30 s. However, this tissue oxygen restoration time can be significantly greater due 
to attenuated reactive hyperaemia in case of patients with sepsis as reported by previous 
studies [30, 38–41]. Hence, it is important to capture and track such changes in real-
time for haemodynamic and perfusion monitoring.
No significant changes in  SvO2 from baseline were observed due to lifting the arm in 
Test 2. These findings suggest variations in peripheral  SvO2 and  O2E are not influenced 
by reduction in peripheral arterial blood flow induced in this test. In particular, one sub-
ject in Test 2 showed elevated  SvO2, for causes yet to be determined. However, possible 
reasons include; (1) increased temperature of the hand to arterialise the venous blood; 
(2) increased vasodilation of peripheral arteries to improve blood flow conditions; or (3) 
over reaction to loss of blood flow.
In addition, Test 2 posed several challenges. First, it was difficult to draw blood when 
the hand was held up, due to reduced venous flow and pressure. Second, a tourniquet 
was employed to increase venous blood volume for sampling, which may have obstructed 
venous flow in the periphery. Hence, Test 3 was later developed to replace Test 2 and 
ensure a robust, reliable, and large  SvO2 change. However, the data from Test 2 still pro-
vided useful for development of the  SpvO2 calibration model, and was thus kept.
Limitations of this study
The primary limitation of this study is the relatively small number (n = 21) of data points 
from a male cohort used to develop the  SpvO2 calibration curve. More data points from 
a gender balanced, larger, and diverse cohort will add robustness to the overall result. 
However, the very strong correlation obtained indicates the concept should generalize 
well.
In particular, this study is only a proof of concept of this pulse oximeter method to 
show the potential over a range of:
  • SvO2 conditions induced to test accuracy across the physiological range.
  • Peripheral blood flow levels that might be seen clinically.
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The study was not about testing full range of people or sex or other conditions. This 
initial test was to show how the concept worked, and quantify how well. Results from 
this initial proof of concept study justify a complete validation trial with more subjects 
and a balanced cohort, in terms of age and sex.
Conclusions
This study presents a non-invasive method to induce venous blood modulations using 
a pneumatic digit cuff (0.2 Hz, 40–50 mmHg inflation pressure), which can be captured 
by PPG. A novel calibration model was derived from venous blood modulated PPG sig-
nals and measured  SvO2 to assess  SpvO2. A strong, linear correlation (r2 =  0.95) was 
found between estimated  RVen and measured  SvO2, with the median difference of 0.29% 
between pairs of measurement, providing a robust calibration and accurate estimate. In 
addition, the gradient of this model (−40.5%) is different to the gradient of the conven-
tional pulse oximeter calibration model (−25%). The proposed  SpvO2 estimation model 
can be used as a potential metric and indicator for low  O2E, consumption, and tissue 
hypoxia.
Real-time estimation of peripheral SvO-2, using this novel pulse oximeter method, and 
 SaO2 will enable continuous, real-time monitoring of these physiological conditions. 
Thus, improvement and application of this novel concept could aid in diagnosis of medi-
cal conditions related to microcirculation dysfunction, such as sepsis and cardiac failure, 
which are both common in the ICU, as well as length of stay, cost, and mortality.
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